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Abstract
Objective—To assess the acceptability and feasibility of a cell-phone based case manager 
intervention targeting HIV-infected pregnant women on highly-active antiretroviral therapy 
(HAART).
Methods—Pregnant women ≥36 weeks gestation attending antenatal care and receiving HAART 
through the Option B+ program at a primary care clinic in South Africa were enrolled into a 
prospective pilot intervention to receive text messages and telephone calls from a case manager 
through six weeks postpartum. Acceptability and feasibility of the intervention were assessed 
along with infant HIV testing rates and 10-week and 12-month postpartum maternal retention in 
care. Retention outcomes were compared to women of similar eligibility receiving care prior to the 
intervention.
Results—Fifty women were enrolled into the pilot from May-July 2013. Most (70%) were 
HAART-naive at time of conception and started HAART during antenatal care. During the 
intervention, the case manager sent 482 text messages and completed 202 telephone calls, for a 
median of 10 text messages and 4 calls/woman. Ninety-six percent completed the postpartum 
interview and 47/48 (98%) endorsed the utility of the intervention. Engagement in 10-week 
postpartum maternal HIV care was >90% in the pre-intervention (n=50) and intervention (n=50) 
periods; by 12-months retention fell to 72% and was the same across periods. More infants 
received HIV-testing by 10-weeks in the intervention period as compared to pre-intervention 
(90.0% vs. 63.3%, p<0.01).
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Conclusions—Maternal support through a cell-phone based case manager approach was highly 
acceptable among South African HIV infected women on HAART and feasible, warranting further 
assessment of effectiveness.
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INTRODUCTION
Despite improved treatment coverage and meaningful reductions in mother-to-child 
transmission (MTCT) in sub-Saharan Africa over the past several years, continued 
improvements in prevention of mother-to-child transmission (PMTCT) programs are 
required if Millennium Development Goals are to be met by 2015 (1). In 2011, the Malawi 
Ministry of Health introduced the Option B+ PMTCT program to close existing 
programmatic gaps (2). Since this time, Option B+, which expands lifelong highly active 
antiretroviral therapy (HAART) to all HIV-infected pregnant women independent of CD4 
cell count and clinical staging, has received endorsement by the World Health Organization 
(3) and has been adopted or considered by more than 20 countries (4). Other countries, such 
as South Africa, are currently offering Option B as the standard of care, which provides 
lifelong treatment for all HIV-infected pregnant women with CD4 cell counts ≤350 mm3, 
while HAART throughout pregnancy and breastfeeding to women with CD4 counts >350 
mm3. Both Option B and B+ programs facilitate rapid HAART initiation by removing 
laboratory and transport times which typically delay immediate treatment initiation when 
dependent on CD4 staging. Rapid treatment initiation of women eligible for HAART is 
important as delayed treatment increases the risk of mother-to-child transmission (5, 6).
However as Option B/B+ programs are scaled up across different settings, program success 
will hinge upon the ability of programs to retain mothers in care not just through delivery, 
but throughout breastfeeding and beyond. A recent South African study found that 58% of 
HIV-infected pregnant women testing positive for HIV during pregnancy were lost-to-care 
by six months postpartum (7). Although early reports from Malawi suggested that Option B
+ programs can retain patients at levels comparable to retention of non-PMTCT patients (8), 
more recent data from across 540 Malawian health centers indicate that women who start 
HAART as part of the Option B+ program were five times more likely not return to the 
clinic after HAART initiation as compared to women who were started on treatment due to 
low CD4 cell counts (9). This evidence raises concerns as how to implement such an 
ambitious program effectively (10).
Case management approaches utilizing face-to-face visits with patients may be one way to 
improve retention in HIV care, however few data are available, particularly in a resource-
limited setting (11–13). Health interventions which utilize mobile phone technology to 
contact patients with text messages require fewer human resources than face-to-face visits 
and have been shown to have a positive impact on adherence to HAART within the general 
population (14, 15). In South Africa where mobile coverage is estimated to be 86% (16), a 
mobile health or mhealth intervention to support pregnant and postpartum mothers, which 
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also includes elements of personal support offered through a case management approach, 
such as telephone calls by a case manager counsellor and face-to-face visits at the clinic, 
could potentially improve postpartum retention in care of mothers and uptake of HIV infant 
testing.
In this paper we present results from a mobile phone-based case management intervention 
piloted at a primary health center implementing Option B+ in South Africa. The objective of 
the study was to assess the acceptability, feasibility and potential for scale-up of the pilot 
intervention.
METHODS
Study context, design and intervention
This study was conducted at Witkoppen Health and Welfare Centre (WHWC), a high 
volume non-governmental primary health clinic in Johannesburg, South Africa, which serves 
the urban township of Diepsloot and surrounding areas. WHWC sees 680 pregnant women a 
month, 33.0% of which are HIV-infected (national HIV prevalence amongst antenatal 
women is 29.5% (17)). While Option B+ is not yet standard of care in South Africa, (18), 
Option B+ was introduced as standard of care at WHWC in November 2012.
The pilot study prospectively enrolled HIV-infected, pregnant women attending antenatal 
care (ANC) at WHWC from May–July, 2013. All HIV-infected pregnant women ≥36 weeks 
gestation, were systematically approached at the ANC clinic and offered participation in the 
case management intervention. Additional eligibility criteria included owning a cell phone, 
being able to read text messages in English, and willingness to receive text messages and 
calls from a case manager (CM). Both women already on HAART at time of pregnancy and 
women not yet HAART-initiated at time of pregnancy were eligible for this study. Written 
informed consent was administered in private rooms by a research assistant. Following 
enrollment, the research team administered baseline questionnaires in English, Zulu or 
Sesotho and then introduced participants to the CM. No remuneration was provided for 
study participation.
The CMs’ overall role was to provide support and motivation for participants to remain in 
care. The two CMs were female, senior HIV lay counselors with previous PMTCT 
counseling experience (only one CM was initially planned and had to be replaced when she 
left for a new position). After enrollment participants were introduced to the CM who 
reviewed study procedures and tested the participant’s cellphone number. The CM then sent 
weekly pre-scripted text messages to the participants’ cellphones which continued until 6 
weeks postpartum (or up to 8 weeks if the participant did not return for the 6 week clinic 
visit). In addition to scheduled text messages, CMs made one pre-delivery and two post-
delivery telephone calls to study participants during follow-up to discuss delivery plans and 
postpartum care. Additional telephone calls were made to the participant if requested by 
free-of-charge “Please Call Me” text messages. Face-to-face contact between the CM and 
participant was limited, although the CM interacted with participants during routine clinic 
visits whenever possible and counseling was available. The CMs maintained participant 
notes, including potential retention barriers, and consulted the notes when calling 
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participants. CMs received logistical support from a part-time project manager and consulted 
clinicians at the clinic when unable to answer technical questions.
Postpartum interviews were conducted at the first clinic visit ≥6 weeks post-delivery or by 
telephone when participants had travelled away from the clinic. The postpartum interviews 
were semi-structured and included both closed and open-ended questions about the 
intervention benefits and acceptability. Maternal and infant medical records were reviewed 
for retention and health outcomes at 10 weeks postpartum; maternal retention in care was 
also assessed at 12 months post-delivery.
The formulation of the intervention was guided by the theory of Information, Motivation and 
Behavioral Skills (IMB) model which stipulates that information and motivation trigger 
behavioral skills that are required to change behavior (19). Content of the text messages thus 
included visit reminders, motivational support, pregnancy and infant-related health 
information, and reminders that participants can send “Please Call Me” messages at any 
time to talk to the CM. Examples of messages sent are provided in a supplemental table. 
Messages did not disclose HIV status or test results. Phone calls focused on visit reminders 
and ascertainment of delivery status, but also included counseling and support as needed.
To contextualize the intervention findings, we conducted a retrospective file review of 50 
HIV-infected, pregnant women attending ANC at WHWC during the period immediately 
preceding the intervention (February–May, 2013). Women in the pre-intervention standard 
of care cohort were eligible for inclusion in the analysis based on the same clinical eligibility 
criteria (HIV-infected and ≥36 weeks gestation) and received Option B+ at the clinic in the 
same manner as the intervention group. As the clinic keeps statistics sheets of all women 
attending ANC, the first 50 eligible women attending care immediately prior to the 
intervention period were selected for the pre-intervention cohort. Whether individuals in the 
pre-intervention cohort could read English text messages is unknown.
Data Analysis
Cohort characteristics and implementation of the intervention are described. Characteristics 
and outcomes between the pre-intervention and intervention cohorts were compared using 
Wilcoxon rank sums and chi-squared statistics to assess differences in medians and 
distributions. Data was entered into RedCap (20) and analysis was performed using Stata 
12.1 (StataCorp, College Station, TX). This research was approved by the institutional 
review boards at the University of North Carolina at Chapel Hill and the Wits Human Ethics 
Committee at the University of the Witwatersrand.
RESULTS
Study population
All women HIV-infected women ≥36 weeks gestation attending ANC at WHWC were 
consecutively screened for study eligibility, including cellphone ownership and ability to 
read English text messages. The first 50 eligible pregnant women were prospectively 
enrolled and followed in a pilot case management intervention. All women screened who 
met the HIV infection and gestational criteria were eligible to participate in the study. Only 
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one eligible woman declined participation in the study. Seventy percent of women enrolled 
initiated HAART during their current pregnancy, while 30% had initiated HAART 
previously. The median CD4 count at the time of the first ANC visit among those initiating 
HAART during pregnancy was 434 cells/mm3 [interquartile range (IQR): 297–515] as 
compared to 539 cells/mm3 [IQR: 303–617] among women who had previously initiated 
HAART (p=0.28).
Overall, women enrolled into the pilot intervention study were similar to women enrolled 
into the pre-intervention standard of care cohort in terms of age, total number of ANC visits, 
HAART history, CD4 count and viral suppression (Table 1).
Implementation and acceptability of the intervention
Figure 1 illustrates the timing of study activities delivered during the pilot intervention 
period. In total, the CM sent 482 texts and attempted 283 telephone calls before and after 
delivery as part of the pilot. Each participant received a median of 10 text messages over the 
course of follow-up [IQR: 9–11], the majority (71%) of which were sent in the postpartum 
period.
Overall 48/50 participants (96%) completed the postpartum questionnaire. In terms of 
acceptability, all but one person (47/48, 98%) indicated that it was helpful to have a CM 
assigned to support them during their pregnancy and postpartum, and all women indicated 
that they would recommend the case management program to a friend. The top reasons 
highlighted were: (1) emotional support, including making the participant feel important and 
that there was someone there for her (62%); (2) educational information and the ability to 
contact the CM directly with questions (21%); and (3) reminders of appointment dates or to 
take medication (15%). The one woman who did not find the intervention useful had 
provided an incorrect number to the CM. In the postpartum questionnaire, none of the 
participants reported an issue with receiving English language texts and 68% identified 
English as one of their preferred languages.
In terms of the frequency of contact, 43/47 (91.5%) women who were successfully contacted 
during the intervention and completed the postpartum questionnaire felt that the number of 
text messages sent and calls made were just right, while the others would have appreciated 
more contact. No participants reported that the contact was too frequent. The majority (70%) 
preferred to receive more post-partum vs. pre-delivery support.
Of the 21 messages piloted, favorite text messages received by participants were: “A healthy 
baby starts with a healthy mother! Be sure to take your tablets every day. To talk to me, send 
a Please Call Me to this number” and “Congratulations on ur new baby! I hope this is a 
special time for you. To talk to me, send a Please Call Me to this number.” No messages 
were indicated as inappropriate.
Regarding telephone conversations, participants listed discussions around HIV treatment 
adherence (56%), infant feeding options (12%), baby preventative treatment and care (9%), 
general support (9%), delivery logistics (e.g. when, where, how to get to delivery location) 
(7%), and healthy living (7%) as the most important topics discussed. In the postpartum 
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interviews, women consistently highlighted the importance of the support and frequently 
mentioned the CM as the only person that was there to support her and give her strength and 
hope.
“The case manager made me feel that I am important and I am not alone. The 
information she gave me was very helpful. Even the support made me survive. 
[Through] the support and consistency in sending SMSs [text messages], the study 
made me believe that there is life after being HIV-positive.” [30 year-old 
participant, newly initiated on HAART]
“She encouraged me to take my tablets. She was the only one knowing my status 
and she was always there for me.” [22 year-old participant, newly initiated on 
HAART]
Overall, 26/50 (52%) women participating in the study contacted their CM at least once 
during study follow-up, either in response to a text message, through “Please Call Me” 
messages, or through unprompted text messages and calls made to the CM. There were no 
major socio-demographic differences between women who initiated contact with the CM as 
compared to women who did not, however those contacting the CM were less likely to have 
disclosed their status to their partner and were less likely to have a known HIV-infected 
partner (Table 2).
Feasibility
We found that one HIV counselor with limited additional training could successfully manage 
a case load of 50 women, which could likely be expanded up to 100 under the current model 
if the text messages were automated and no outside counseling duties were required. Need 
for consultation by the CM from clinicians external to the study was infrequent (<5 times 
over four months), however the project manager was a nurse and provided occasional 
assistance to the CM.
In terms of feasibility of contacting participants through cellphones, the CM successfully 
spoke with 56% of the enrolled women at least once prior to delivery and 92% of women in 
the postpartum period. Combined, the CM successfully talked to 96% of women at least 
once over the phone during the study and reached each participant by phone a median of 4 
times [IQR: 2–5]. The median call duration was 1 minute and 2 seconds, however calls 
ranged from 6 seconds to 14 minutes and 35 seconds.
Only one woman was never reached by the CM, but indicated during a later clinic visit that 
she had provided the study team with an incorrect telephone number. Two other women later 
became unreachable and two other women reported lost cellphones during study follow-up, 
limiting contact with the CM. An additional woman requested the CM to stop contacting her 
during the postpartum period, indicating that someone else was reading her messages. 
Overall, telephone contact was maintained at 6-weeks postpartum with 44/50 (88%) women 
enrolled.
The primary costs associated with implementing the intervention were salary for a senior 
HIV lay counselor, part-time assistance by the project manager organizing text and calling 
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schedules, R3,631 (USD 364) in total cellular communication costs over 4 months (R73 per 
participant [USD 7]), and R289 (USD 29) for a basic mobile phone for the CM. A small 
private space for calling/counseling activities was also required.
Maternal retention in care and infant testing outcomes
In the pre-intervention period (n=50) there was one stillborn and one infant diagnosed with 
HIV. During the pilot period (n=50) all pregnancies resulted in a live birth and no infant 
deaths or infant infections were recorded. Table 3 presents maternal and infant engagement 
in care. Throughout both the pre-intervention and pilot periods ≥90% of women attended 
WHWC to collect their HIV medication at least once during the first 10 weeks postpartum. 
In the pre-intervention and intervention periods, 100% of women who had initiated HAART 
prior to pregnancy collected their medication at least once by 10 weeks post-delivery, 
compared to 88% of women who initiated HAART during pregnancy (p=0.09). At 12 
months post-partum, 21/23 (91%) of women on HAART prior to pregnancy remained 
engaged in ART care, whereas 48/77 (62%) of women initiated on HAART during or soon 
after pregnancy remained actively engaged in care at the clinic (p<0.01). There were no 
significant differences in 12-month maternal retention in ART care between women in the 
pre and post intervention periods. In terms of infant testing, 38/50 (76%) infants in the pilot 
period received infant polymerase chain reaction (PCR) HIV testing at the recommended six 
weeks as compared to 22/49 (45%) among infants in the pre-intervention period (p<0.01). 
By ten weeks, testing increased in both groups, but remained statistically significantly higher 
in the pilot group (90% vs. 63%, p<0.01).
DISCUSSION
We found the pilot intervention to provide support to HIV-infected women on HAART 
during late pregnancy and for six weeks postpartum to be feasible and highly acceptable. 
Post-partum contact at 6-weeks was maintained via cellphone with 88% of enrolled women 
and via telephone or clinic visits amongst 96%. We did not find that willingness to 
participate was different between women newly initiated on HAART and women who had 
been on HAART prior to coming for ANC. The sustained contact maintained with study 
participants throughout the 6-week postpartum period and the substantial proportion of 
participants (52%) who directly contacted the CM further support the feasibility and 
acceptability of a cellphone-based case management intervention to target women in 
PMTCT programs.
High acceptability and feasibility alone may not warrant further intervention evaluation if 
there is no initial indication that the intervention may have a public health impact. Maternal 
and infant outcomes in the pre-intervention and pilot periods were assessed to better 
understand the potential merit of the intervention. We compared results of women 
participating in the intervention to similar women receiving care prior to the pilot. Overall 
we found high retention in care among both pre-intervention (96%) and intervention 
participants (94%) at 10-weeks postpartum. By 12 months retention in ART care dropped to 
72% in the intervention period and 66% pre-intervention. Thus while the retention at 10-
weeks was much higher than those in other B+ settings like Malawi, by 12-months the 
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results were comparable(8, 9). This highlights that the duration of an effective intervention 
would likely need to continue well beyond six weeks post-partum. Our findings also 
emphasize that the women in greatest need for interventions are those initiated on HAART 
during pregnancy. Despite these challenges with maternal retention, early infant testing rates 
were substantially higher among intervention participants, a finding that is encouraging and 
supports the notion this approach could potentially result in improved infant HIV testing 
uptake.
Facility and community-based interventions in Mozambique and Malawi have previously 
demonstrated improved infant testing rates. In Malawi a case management pilot study using 
community health workers achieved an HIV infant testing rate of 81%, although there was 
no comparison group and long-term retention of mothers in ART treatment programs was 
not assessed (13). A facility-based intervention in Mozambique was able to increase infant 
testing uptake by more than three times through an enhanced referral process that escorted 
women to the testing site (21), however this approach only reaches women who have already 
returned to the health facility in the postpartum period. Currently there are large mhealth 
initiatives focused on PMTCT in South Africa, including the Mobile Alliance for Maternal 
Action (www.mobilemamaalliance.org) and mothers2mothers (http://www.m2m.org), 
among others. The content of these initiatives range from mobile phone provision and SMS 
messages to peer support from ‘Mentor Mothers’ (22, 23). These initiatives have undergone 
rapid expansion reinforcing the acceptability of mobile-based initiatives, however rigorous 
evaluations to assess the effectiveness of interventions have been more limited. The South 
African government has recently adopted a text message program for pregnant women called 
MomConnect (http://www.praekeltfoundation.org/mom-connect.html) which will subsidize 
text messaging during pregnancy and postpartum. Thus the generalizability of mobile phone 
interventions within South Africa is broad and efficacy data are needed. However the 
applicability of mobile interventions in countries outside of South Africa and even within 
some rural areas of South Africa may be more limited. It is also possible that the poorest and 
most vulnerable women may not have cell phones, but are still in need of adherence support. 
Feasibility and acceptability of interventions in these other contexts should also be 
evaluated.
Emotional and motivational support particularly during the postpartum period, were most 
frequently cited by participants in our study as the greatest participation benefits. Based on 
the differences between patients who did and did not directly contact the CM, it appears that 
this support may be particularly important for women who have HIV-uninfected partners or 
partners of an unknown HIV status, suggesting that the CM may in many cases fill some of 
the support needs that they are not getting from their partner. While we anticipated that 
women who had not disclosed their HIV-infection status to their partner may have been 
more concerned about communicating with a CM, we found the opposite: women who had 
not disclosed to their partner were actually more likely to contact the CM. We did not detect 
a significant difference between women contacting their CM if they initiated HAART during 
the current pregnancy as compared to prior to this pregnancy, however there was a trend. 
Together, these findings indicate that case management support may be particularly 
important for women newly initiated on HAART and those with less partner support.
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We demonstrated the study’s feasibility but identified much room for improvement. Manual 
texting was time consuming. An automated system would decrease the CM workload, 
however transitioning from pre-delivery to postpartum messaging necessitates delivery 
confirmation, and we found that expected delivery dates are frequently off by two weeks or 
more. Potential incentives, such as phone credit, to encourage participants to inform the CM 
when they deliver could also aid implementation and ensure that messaging is properly 
targeted to the pre and postpartum periods. The study underwent changes in personnel 
during the intervention. Thus additional counselors were used to help support the 
intervention during the hiring of a new CM. Despite the turnover, there were no complaints 
or attrition that was attributed to a rotating case management support team.
Our study has limitations. As a pilot, the primary purpose of the study was to access 
acceptability and feasibility of the case management intervention. Thus, the study was not 
powered or designed to assess efficacy. However d based on the 12-month retention data 
presented here, the intervention duration would likely need to be extended in order to have 
an impact on long-term maternal retention in ART care. Furthermore we only collected 
prospective data and completed questionnaires with women enrolled in the pilot 
intervention. Pre-intervention data was collected retrospectively to obtain an understanding 
of the potential efficacy of the intervention and ability to read English texts in the pre-
intervention period was not assessed. Despite this limitation, none of the participants 
screened in the intervention period were ineligible based on the language criteria and a 
larger intervention would be encouraged to translate messages into additional languages.
Furthermore, outside of the intervention, there were no changes in clinical care or 
educational messages at the clinic between the pre and post-intervention periods which were 
adjoining, and to our knowledge there were no differences in community educational 
campaigns during these periods either. Finally, the intervention implemented involved two 
components, a text message strategy and a case management approach. The cost 
implications of the two strategies are different and future work should attempt to tease out 
the comparative effectiveness of each strategy. Thus, based on our findings, a randomized 
intervention with an extended implementation period which assesses costs and effectiveness 
of these separate strategies to improve maternal and infant outcomes over a longer period of 
follow-up is warranted.
As Option B and B+ continue to be rolled out across Sub-Saharan Africa, approaches to 
maximize not only the immediate prevention benefits of maternal HAART during 
pregnancy, but also the long-term benefits to mothers and infants of lifelong treatment 
through sustained retention in care will be necessary. Women starting HAART during 
pregnancy are faced with many rapid changes in their lives and additional support – 
particularly in the postpartum period – may help women adjust to taking HAART for their 
own health and not just to prevent transmission to the infant while pregnant. In our 
experience, a case management cellphone-based approach demonstrates potential for 
providing this support and encouraging a positive, lasting relationship between clinic and 
patient.
SCHWARTZ et al. Page 9














We are grateful to the Witkoppen Health and Welfare Centre team and patients for their time and for making this 
study possible. The support of Thembisile Makhomboti and all of the staff at the antenatal clinic was essential to 
this research. We would also like to thank Ntombenhle Shipalana, Nokuthula Mcunu and Mantombi Ntuli at 
Witkoppen Health and Welfare Centre for assistance with this study and for the dedication they provided to the 
participants. Clarence Potter at the North Carolina Translational Clinical Sciences Institute provided the study with 
REDCap database support. This study was funded by the United States Agency for International Development 
(USAID) under award number AID6741200033. Sheree Schwartz received support for this work from the UJMT 
Fogarty Grant, supported by the Fogarty International Center of the National Institutes of Health under Award 
Number R25TW009340. SS, KC, AVR, JB & AP conceived of the study; the study was implemented by NY, SS, 
KC, JB and MR. Data analysis was done by SS. Writing, interpretation of results and intellectual contribution to the 
paper were contributed by all authors. All authors have read and approved the text as submitted. The content is 
solely the responsibility of the authors and does not necessarily represent the official views of USAID or the 
National Institutes of Health.
References
1. World Health Organization. UNAIDS report on the global AIDS epidemic. 2013
2. Malawi Ministry of Health. Clinical Management of HIV in Children and Adults. 2011
3. World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating 
and Preventing HIV Infection: Recommendations for a public health approach. 2013
4. Ryan C. The Critical Role of High Impact Interventions in Achieving an AIDS-Free Generation. 
International Conference on AIDS and STIs in Africa. 2013 Oral presentation. 
5. Hoffman RM, Black V, Technau K, et al. Effects of highly active antiretroviral therapy duration and 
regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir 
Immune Defic Syndr. 2010; 54(1):35–41.10.1097/QAI.0b013e3181cf9979 [PubMed: 20216425] 
6. Chibwesha CJ, Giganti MJ, Putta N, et al. Optimal time on HAART for prevention of mother-to-
child transmission of HIV. J Acquir Immune Defic Syndr. 2011; 58(2):224–8.10.1097/QAI.
0b013e318229147e [PubMed: 21709566] 
7. Clouse K, Pettifor A, Shearer K, et al. Loss to follow-up before and after delivery among women 
testing HIV positive during pregnancy in Johannesburg, South Africa. Tropical medicine & 
international health: TM & IH. 2013; 18(4):451–60.10.1111/tmi.12072 [PubMed: 23374278] 
8. Centers for Disease Control and Prevention. Impact of an innovative approach to prevent mother-to-
child transmission of HIV–Malawi, July 2011-September 2012. MMWR. Morbidity and mortality 
weekly report. 2013; 62(8):148–51. [PubMed: 23446514] 
9. Tenthani L, Haas AD, Tweya H, et al. Retention in care under universal antiretroviral therapy for 
HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi. AIDS. 2014; 28(4):589–
98.10.1097/QAD.0000000000000143 [PubMed: 24468999] 
10. Shaffer N, Abrams EJ, Becquet R. Option B+ for prevention of mother-to-child transmission of 
HIV in resource-constrained settings: great promise but some early caution. AIDS. 2014; 28(4):
599–601.10.1097/QAD.0000000000000144 [PubMed: 24469000] 
11. Craw JA, Gardner LI, Marks G, et al. Brief strengths-based case management promotes entry into 
HIV medical care: results of the antiretroviral treatment access study-II. J Acquir Immune Defic 
Syndr. 2008; 47(5):597–606.10.1097/QAI.0b013e3181684c51 [PubMed: 18285714] 
12. Gardner LI, Metsch LR, Anderson-Mahoney P, et al. Efficacy of a brief case management 
intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005; 19(4):423–31. 
[PubMed: 15750396] 
13. Kim MH, Ahmed S, Buck WC, et al. The Tingathe programme: a pilot intervention using 
community health workers to create a continuum of care in the prevention of mother to child 
transmission of HIV (PMTCT) cascade of services in Malawi. Journal of the International AIDS 
Society. 2012; 15(Suppl 2):17389.10.7448/IAS.15.4.17389 [PubMed: 22789644] 
14. Mbuagbaw L, van der Kop ML, Lester RT, et al. Mobile phone text messages for improving 
adherence to antiretroviral therapy (ART): an individual patient data meta-analysis of randomised 
trials. BMJ open. 2013; 3(12):e003950.10.1136/bmjopen-2013-003950
SCHWARTZ et al. Page 10













15. Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile phone technologies improve 
adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of 
text message reminders. AIDS. 2011; 25(6):825–34.10.1097/QAD.0b013e32834380c1 [PubMed: 
21252632] 
16. South African Audience Research Foundation. Cell Phone Trends. Available at: http://
www.saarf.co.za/amps/cellphone.asp. [Accessed January 30, 2014].
17. Republic of South Africa Department of Health. The 2011 National Antenatal Sentinel HIV & 
Syphilis Prevalence Survey in South Africa. 2012
18. Republic of South Africa Department of Health. The South African Antiretroviral Treatment 
Guidelines: PMTCT Guidelines Revised March 2013. 2013
19. Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychological bulletin. 1992; 111(3):455–74. 
[PubMed: 1594721] 
20. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)–a metadata-
driven methodology and workflow process for providing translational research informatics 
support. Journal of biomedical informatics. 2009; 42(2):377–81.10.1016/j.jbi.2008.08.010 
[PubMed: 18929686] 
21. Ciampa PJ, Burlison JR, Blevins M, et al. Improving retention in the early infant diagnosis of HIV 
program in rural Mozambique by better service integration. J Acquir Immune Defic Syndr. 2011; 
58(1):115–9.10.1097/QAI.0b013e31822149bf [PubMed: 21546845] 
22. World Health Organization. Supporting pregnant women and new mothers in South Africa Cell-
Life’s MAMA SMS2013. 
23. Baek, CMV.; Mkhize, S.; Friedman, I.; Apicella, L.; Rutenberg, N. Horizons Final Report: Key 
findings from an evaluation of the mothers2mothers program in KwaZulu-Natal, South Africa. 
Washington: 2007. 
SCHWARTZ et al. Page 11














Description of activities during the pilot intervention
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Table 1
Characteristics of pregnant women enrolled into research at the antenatal clinic
Characteristics Women enrolled in the pilot study (n=50)
Women enrolled into pre-
intervention cohort (n=50) p-value
†
Age (years), median [IQR] 28 [26–34] 29 [26–33] 0.46
Gestational weeks at time of first ANC visit, median [IQR] 22 [15–27] 21 [14–26] 0.86
Gestational weeks at time of study enrollment, median [IQR] 37 [36–38] 37 [36–38] 0.27
Total number of ANC visits during pregnancy, median [IQR] 6 [5–7] 6 [4–7] 0.94
HAART status at time of pregnancy, n (%)
 Initiated HAART prior to current pregnancy 15 (30%) 8 (16%)
0.11 Initiated on HAART during current pregnancy 35 (70%) 40 (80%)
 Not initiated on HAART during current pregnancy 0 (0%) 2 (4%)§
Average months on HAART at enrollment, median [IQR] 3.7 [1.9–10.4] 3.2 [1.9–4.9] 0.45
Most recent CD4 count at enrollment‡
 ≤350 cells/mm3 15 (31%) 13 (28%)
0.87 351–500 cells/mm3 16 (33%) 15 (32%)
 >500 cells/mm3 17 (35%) 19 (40%)
Most recent viral load at enrollmentψ
 Suppressed at <50 copies/ml 7 (30%) 5 (24%)
0.62
 Detectable virus ≥50 copies/ml 16 (70%) 16(76%)
†
Comparisons of medians and distributions estimated using Wilcoxon rank sum and chi-squared statistics respectively.
§
Two women in the pre-intervention period were not initiated on HAART during pregnancy as they requested to delay initiation until they felt more 
ready; zidovudine was initiated for these women during pregnancy and maternal HAART was later initiated in the post-partum period.
‡
2 women enrolled in the pilot study and 3 women part of the pre-intervention cohort did not have CD4 cell counts on record at time of enrollment 
in to the study.
ψ
For patients initiating HAART, baseline viral loads are not taken. However viral loads were assessed during pregnancy among women initiated for 
at least three months; thus by 36–40 weeks gestation, some women initiated during pregnancy had a viral load taken. For this reason viral loads at 
time of enrollment into the study were available for some women not on HAART prior to pregnancy, however viral loads were not available for 27 
women in the pilot and 29 women in the pre-intervention period.
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Table 2
Comparison of characteristics of women who initiated contact with the case manager
Characteristics Did not contact CM directly (n=24) Contacted CM directly (n=26) p-value†
Age (years), median [IQR] 28 [26–33] 29 [26–35] 0.41
Employed, (%) 66.7% 57.7% 0.51
Monthly income, median USD [IQR] 278 [197–414] 253 [182–354] 0.72
Prior parity, (%)
 No children 20.8% 26.9%
0.61
 One or more children already at time of pregnancy 79.2% 73.1%
Reported pregnancy was planned, (%) 21.7% 42.3% 0.13
Planned/known travel before or after delivery, (%) 29.2% 19.2% 0.41
HAART status at time of pregnancy, (%)
 Initiated HAART prior to current pregnancy 37.5% 23.1%
0.27
 Initiated on HAART during current pregnancy 62.5% 76.9%
Currently has a partner, (%) 87.5% 88.5% 0.92
Partners’ HIV Status, (%)
 HIV infected 52.4% 17.4%
0.04 HIV uninfected 14.3% 13.0%
 HIV status unknown 33.3% 69.6%
Disclosed HIV status to male partner, (%) 100% 73.9% 0.01
†
Comparisons of medians and distributions estimated using Wilcoxon rank sum and chi-squared statistics respectively.
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Table 3
Engagement in postpartum HIV clinical care among women and babies




Maternal Engagement in Care
At least one of more ARV pick-ups after delivery (between 0–10 weeks 
postpartum) 46 (92%) 45 (90%) 0.73
Actively engaged in HIV care at 10 weeks or transferred out to another site 47 (94%) 48 (96%) 0.65
ART retention at 12-months post-delivery
 Active at clinic 36 (72%) 33 (66%)
0.71 Transferred out 3 (6%) 5 (10%)
 Lost to follow-up 11 (22%) 12 (24%)
Infant Engagement in Care
Known to have received PCR at WHWC or elsewhere at 6 wks 38 (76.0%) 22 (44.9%) <0.01
Known to have received PCR at WHWC or elsewhere by 10 wks 45 (90.0%) 31 (63.3%) <0.01
†
Comparisons between groups estimated using chi-squared statistics respectively.
‡
The denominator for infant outcomes in the pre-intervention period is 49, as one pregnancy resulted in a stillbirth.
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